Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

HemoCept Inc.

Status: Enrolling

Conditions: Congestive Heart Failure(CHF); Valve Disease, Heart; Pulmonary Hypertension

Study type: Observational

Funder types: Industry

Identifiers

NCT07224906

PRT-020

Details and patient eligibility

About

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
• Subjects can be any gender but must be age 18 or older.
• Subject is able and willing to provide informed consent and HIPAA authorization.
• Subject is able and willing to meet all study requirements.
• Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

Exclusion criteria

• Subject is pregnant, breastfeeding, or intends to become pregnant during this study.